Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis.

Literature DB >> 12079721

Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis.

Frank A Anania, Lionel Rabin.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 12079721 DOI： 10.1016/s0002-9343(02)01109-9

Source DB: PubMed Journal: Am J Med ISSN： 0002-9343 Impact factor: 4.965

Keyword Cloud
Cited

× No keyword cloud information.

6 in total

1. Terbinafine induced liver injury: a case report.

Authors: Narendra S Choudhary; Hardik Kotecha; Neeraj Saraf; Dheeraj Gautam; Sanjiv Saigal
Journal: J Clin Exp Hepatol Date: 2014-04-03

2. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.

Authors: Robert John Fontana; Elizabeth Theresa Cirulli; Jiezhun Gu; David Kleiner; David Ostrov; Elizabeth Phillips; Ryan Schutte; Huiman Barnhart; Naga Chalasani; Paul Brent Watkins; Jay H Hoofnagle
Journal: J Hepatol Date: 2018-08-21 Impact factor: 25.083

3. Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.

Authors: Emanuel Raschi; Elisabetta Poluzzi; Ariola Koci; Paolo Caraceni; Fabrizio De Ponti
Journal: World J Hepatol Date: 2014-08-27

Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis.

1. Terbinafine induced liver injury: a case report.

2. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.

3. Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database.

4. Death and liver transplantation within 2 years of onset of drug-induced liver injury.

Review 5. Drug-induced liver injury: is it somehow foreseeable?

6. Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality.